Asthma Archives - Express Pharma

Cipla launches CipAir App for asthma screening in India

12-month diagnosed prevalent cases of severe asthma across 8MM to reach 1.89 million in 2033, forecasts GlobalData

Our collaborations with Govt of India focus on building resilient healthcare systems

Alkem Laboratories launches awareness initiative ‘Stop Sneeze to Wheeze’

Alkem launches inhalation device – Innohaler for Asthma and COPD patients

Lupin gets UK marketing authorisation for Luforbec 100/6 µg pMDI

AstraZeneca Pharma India gets DCGI nod for benralizumab injection, Fasenra

FASENRA eliminated OCS in a majority of asthma patients in PONENTE Phase IIIb trial

GSK gets US FDA approval for Trelegy Ellipta to treat asthma, COPD

Lupin gets US FDA approval for generic Albuterol Sulphate MDI